HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Depeng Jiang, Speaker at Vaccines Conferences
Keynote Presentation (In-person)
Depeng Jiang, University of Manitoba, Canada

Vaccines can exhibit varying delayed effects among individuals, posing challenges in trial design and analysis when using the log-rank test. This can lead to significant power loss and complexities in making interim decisions in adaptive designs. In this presentation, we introduc [....] » Read More

Julissa Soto, Speaker at Immunity Conferences
Oral Presentation (In-person)
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States

Description of Presentation: Cultural Validation is a critical tool for bridging gaps between public health agencies and the communities they serve. At the onset of the COVID-19 Pandemic, policymakers and public health officials often cited “vaccine hesitancy” as a ke [....] » Read More

Lindsay Parish, Speaker at Immnuology Conferences
Oral Presentation (In-person)
Lindsay Parish, BARDA, United States

The mission of the Biomedical Advanced Research and Development Authority (BARDA) as part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, is to enhance the U.S. government’s capability to respond to chem [....] » Read More

Prasoon Sheoran, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Prasoon Sheoran, Directorate of Health and Family Welfare, India

Background: Case based surveillance is effective in preventing and controlling the incidence of infectious disease. VPD surveillance was first launched in Haryana state of India in 2014. We evaluated the system to identify its strengths and gaps. Methods: A descriptive cross s [....] » Read More

Ismail Hossain, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Ismail Hossain, Globe Biotech, Bangladesh

Antibiotic resistance is now a days one of the biggest challenges headed by the health professionals globally, it is causing more quickly due to the misuse and overuse of antibiotics. Bacteria are becoming resistant to commonly used antibiotics and various factors have been ident [....] » Read More

Fisseha Shiferie Tadesse, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Fisseha Shiferie Tadesse, Project HOPE, Ethiopia

Background: Ethiopia is the fourth leading contributor to the global total of zero-dose children (those who lack the first dose of the pentavalent vaccine) and has substantial regional variations in zero-dose children. This study explored the spatial pattern of zero-dose children [....] » Read More

Samson Gebremedhin Gebreselassie, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Samson Gebremedhin Gebreselassie, Project HOPE, Ethiopia

Background: Uninterrupted availability of potent vaccines requires robust vaccine supply chain and logistics system (VSCLS). With special focus on remote and underserved settings, we assessed the reach and bottlenecks to end-to-end delivery of the Ethiopian VSCLS after the initia [....] » Read More

Bhoj R Singh, Speaker at Vaccine Research Conference
Oral Presentation (In-person)
Bhoj R Singh, Indian Veterinary Research Institute, India

In India, many disease control programs for vaccine-preventable diseases have been running for several decades but such diseases are regularly haunting India. Why? Is it poor vaccine quality, vaccination defect or both? To understand the dilemma we may take the example of the Nat [....] » Read More

Daniel Workineh Aynew, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Daniel Workineh Aynew, Debre Markos University, Ethiopia

Infectious bursal disease (IBD) is an immunosuppressive and economically important disease of young chickens caused by infectious bursal disease virus (IBDV). The National Veterinary Institute (Bishoftu, Ethiopia) produces intermediate IBDV vaccine using primary chicken embryo fi [....] » Read More

Gashaw Andargie Biks, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Gashaw Andargie Biks, Project HOPE, Ethiopia

Background: Increasing attention is being given to reach children who fail to receive routine vaccinations, commonly designated as zero-dose children. A comprehensive understanding of the supply- and demand-side barriers is essential to inform zero-dose strategies in high-bu [....] » Read More

Ping Xie, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Ping Xie, Associate Professor , United States

Myeloid cells are the major players of innate immunity and inflammation. The functionality of myeloid cells is controlled by innate immune receptor signaling, which is critically regulated by a cytoplasmic adaptor protein termed TRAF3. Ablation of TRAF3 from myeloid cells does no [....] » Read More

Emily Maxwell, Speaker at Immunology Conferences
Oral Presentation (In-person)
Emily Maxwell, University of Alaska Fairbanks, United States

Background: Vaccine hesitancy is one of the principal causes behind decreasing vaccination rates in the United States. Many factors can contribute to vaccine hesitancy, including misinformation, lack of trust in institutions, cultural or religious beliefs, personal experience, an [....] » Read More

Rajesh Kumar Gautam, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Rajesh Kumar Gautam, A Central University, India

The outbreak of COVID-19 has severely affected the world with devastating consequences. It has unprecedented effect on lives, livelihoods, economies, and so on. Several potential vaccines have been developed to combat from COVID-19. Despite this success and the availability of va [....] » Read More

Madhu Khanna, Speaker at Immunology Conferences
Oral Presentation (In-person)
Madhu Khanna, University of Delhi, India

Dengue, a significant global health challenge, is caused by four co-circulating serotypes (DENV 1-4) of the virus. Viral infections not only result in health complications and fatalities among infected individuals, but it also depletes limited resources intended for preventing in [....] » Read More

Sean Yanik, Speaker at Vaccine Conferences
Poster Presentation (In-person)
Sean Yanik, Johns Hopkins, United States

In 2021, there were 247 million clinical cases and 619,000 deaths from malaria. RTS, S, the first and only WHO approved vaccine for malaria, targets the pre-erythrocytic stage antigen circumsporozoite protein (CSP) and provides only limited efficacy, reducing clinical malaria by [....] » Read More

Sean Yanik, Speaker at Vaccine Conferences
Poster Presentation (In-person)
Sean Yanik, Johns Hopkins, United States

In 2022, there were an estimated 249 million clinical cases and 608,000 deaths from malaria. A vaccine against Plasmodium falciparum would provide a critical tool for malaria control and eventual eradication. RTS,S, the first WHO approved vaccine for malaria, targets the antigen [....] » Read More

Yen Hung Chow, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Yen Hung Chow, National Health Research Institutes, Taiwan

Enterovirus A71 (EV-A71) and coxsackievirus A (CVA) were the primary causative agents of hand, foot, and mouth disease (HFMD), the heightened occurrence of HFMD outbreaks associated with CVA10 worldwide has questioned this perspective. Due to the absence of an effective vaccine o [....] » Read More

Subodh Adhikari, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Subodh Adhikari, Maharajgung Medical Campus, Nepal

Introduction: Vaccination against Coronavirus Disease 2019 (COVID-19) is essential for controlling the ongoing cases of this disease. Citrobacter infections of the bones and joints are extremely uncommon. Thromboembolism and deep vein thrombosis are very rare complications. Ca [....] » Read More

Hallie Cope, Speaker at Immunology Conferences
Poster Presentation (In-person)
Hallie Cope, Ipsos, United States

The production, distribution and administration of the COVID-19 vaccines was pivotal in changing the course of the pandemic; however, relative uptake of the vaccines varied across regions. The Ipsos Global Core Vaccines Study is a multi-country, multi-centre, online, consumer [....] » Read More

Anosha Nangraj, Speaker at Vaccine Research Conference
Poster Presentation (In-person)
Anosha Nangraj, Habib University, Pakistan

Safe and readily available water is integral for public health. Karachi (Pakistan), ranked number 11 as the most populous metropolitan city in the world, is heavily impacted by the critical issue of water contamination. Shrines in Karachi, do not only serve as a place of worship [....] » Read More

Gashaw Andargie Biks, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Gashaw Andargie Biks, Project HOPE, Ethiopia

Background: The WHO/UNICEF estimates that over 18 million children in low- and middle-income countries, especially in Africa and South-East Asia, are not being vaccinated, with Ethiopia being one of the top four countries contributing to this issue. Objective: To estimate [....] » Read More

Abebe Aga, Speaker at Vaccine Research Conference
Oral Presentation (In-person)
Abebe Aga, Armauer Hansen Research Institute, Ethiopia

Rabies is 100% fatal zoonotic disease with acute encephalitis in humans and animals. The case is most severe in developing countries where cell culture derived anti-rabies vaccines are unaffordable or the available nervous tissue-derived vaccines are of questionable immunogenicit [....] » Read More

Barthalomew Wilson, Speaker at Vaccine Research Conference
Oral Presentation (In-person)
Barthalomew Wilson, PREVAIL, Liberia

Lassa fever is a public health threat, with an estimated 500,000 cases reported annually in West Africa. The International AIDS Vaccine Initiative (IAVI) and the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) launched a phase 1 Lassa fever vacci [....] » Read More

Anirban Sukul, Speaker at Vaccine Research Conference
Oral Presentation (In-person)
Anirban Sukul, Director, Sukul Institute of Homeopathic Research , India

High dilutions (HDs) of drugs used in Homeopathy are identical in the composition containing ethanol and water. Yet they show specific therapeutic action on patients. Aims: HDs prepared by serial dilution and succussion are called potencies. Do the potency ranks show any differen [....] » Read More

Jun Wan, Speaker at Immunology Conferences
Oral Presentation (In-person)
Jun Wan, Indiana University School of Medicine, United States

We explored distinct and comprehensive patterns of SARS-CoV-2 genetic variations, offering insights obtained by sophisticated analyses from diverse perspectives. Our study encompassed an in-depth examination of single nucleotide variants (SNVs), various nucleotide substitutions, [....] » Read More

Gasana Joel, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Gasana Joel, Rwanda Biomedical Centre, Rwanda

The policy brief titled "Immunization Saves Lives: Maintaining Good Immunization Coverage To Prevent Potential Outbreaks" addresses the critical importance of sustaining high immunization coverage rates, especially in light of disruptions caused by global health emerg [....] » Read More

Mahinn Abdullah, Speaker at Vaccine Research Conference
Oral Presentation (In-person)
Mahinn Abdullah, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan

The reputable Economist magazine, posed a question in its Sep. 2020 issue that “Is Pakistan really handling the pandemic better than India?” In this paper we will endeavour to statistically answer this question, and submit possible explanations supporting our results. [....] » Read More

Ali Abbaszade Cheragheali, Speaker at Vaccine Research Conference
Oral Presentation (Virtual)
Ali Abbaszade Cheragheali, Torbat Heydariyeh University of Medical Sciences, Iran (Islamic Republic of)

In the rapidly evolving field of vaccine development, nanotechnology has emerged as a revolutionary approach, promising to redefine the boundaries of immunization strategies. This paper aims to explore the multifaceted role of nanotechnology in vaccine formulation, highlighting i [....] » Read More

Dalinda Eusebio, Speaker at Vaccine Research Conference
Oral Presentation (Virtual)
Dalinda Eusebio, CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal

Coronavirus disease (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has resulted in 775 million confirmed cases and approximately 7 million deaths reported by the World Health Organization (WHO) as of 31 March [....] » Read More

Junaid Nazir, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Junaid Nazir, Skuast k, India

Salmonellosis poses a serious threat to the poultry industry, causing huge economic losses and posing risks to human health. Vaccination is essential for controlling Salmonella infection in poultry, and there is growing interest in alternative vaccine del [....] » Read More

Pritish Mankar, Speaker at Vaccine Research Conference
Oral Presentation (Virtual)
Pritish Mankar, Tashkwnt Medical University, India

Introduction Healthcare workers are the backbone of the healthcare system, providing essential services to patients and playing a critical role in public health. Despite their importance, healthcare workers face significant stressors that can adversely affect their mental hea [....] » Read More

Arbind Chhetri, Speaker at Vaccine Research Conference
Oral Presentation (Virtual)
Arbind Chhetri, Tashkent Medical Academy, Uzbekistan

Introduction : Acute myocardial infarction (AMI) is a leading reason for death around the world, typically made complex by numerous arrhythmias. Comprehending the occurrence plus patterns of these arrhythmias in hospitalized AMI people is important for maximizing administration t [....] » Read More

Souhir Ayadi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Souhir Ayadi, Faculty of Medicine, Tunisia

Introduction: The COVID-19 vaccination campaign started in 2021 was a crucial step in significantly reducing mortality, especially among elderly people at high risk of serious forms. However, its impact on the progression of the disease has not been a frequent subject of research [....] » Read More

Souhir Ayadi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Souhir Ayadi, Faculty of Medicine, Tunisia

Introduction:  Klebsiella pneumoniae is a gram-negative bacterium that has become a well-recognized cause of nosocomial infections. Hospital outbreaks due to multiresistant K.pneumoniae strains have been described throughout the world. We aimed to describe the occurrenc [....] » Read More

Nzolameso Makaya Jennifer, Speaker at Immunology Conferences
Poster Presentation (In-person)
Nzolameso Makaya Jennifer, Hopital General De Reference De Kimbanseke Pierre Pokom, Congo

70% of people over 65 are hypertensive; high blood pressure increases the risk of exposure to cardiovascular disease (myocardial infarction and heart failure) and stroke. This is a public health problem, given the aging of the population. There are few studies carried out in eld [....] » Read More

Akumu Esther Joy, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Akumu Esther Joy, Infectious Diseases Institute, Uganda

Background: Coronavirus disease (COVID-19) was declared a pandemic by the World Health Organization (WHO) on 11th March 2020. COVID-19 vaccination is one of the strategies that was employed to contain COVID-19 infection. In Uganda, COVID-19 vaccination campaigns began in Mar [....] » Read More

Fonguh Oliver Khan, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Fonguh Oliver Khan, Ministry of Public Health , Cameroon

Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 individuals have shown promise in prevention. We have previously demonstrated that the IgG3 isotype significantly improved the neutralization potency of CAP256-VRC26.25 over the routinely used IgG1 constant region. Howev [....] » Read More

Gebeyehu Assefa Mitku, Speaker at Vaccine Research Conference
Poster Presentation (In-person)
Gebeyehu Assefa Mitku, Armauer Hansen Research Institute, Ethiopia

Background: Drug-resistant tuberculosis (TB) epidemic in high-TB-incidence countries, particularly Ethiopia, remains a significant challenge. As a result, we investigated the drug resistance, common gene mutation, and molecular characterization of mycobacterial isolates from pati [....] » Read More

Harsh Chaudhary, Speaker at Vaccines Conferences
Poster Presentation (Virtual)
Harsh Chaudhary, Tashkent Medical Academy, Uzbekistan

Introduction: Peptic ulcer disease (PUD) is a prevalent gastrointestinal disorder characterized by mucosal erosion in the stomach or duodenum, often leading to abdominal pain, bleeding, and perforation. Despite advances in understanding and treatment, PUD remains a significant pu [....] » Read More

Pratishthi Sharma, Speaker at Immunology Conferences
Poster Presentation (Virtual)
Pratishthi Sharma, Tashkent Medical Academy, Uzbekistan

Introduction: Transient ischemic stroke (TIA) is a critical neurological event characterized by temporary disruption of blood flow to the brain, leading to transient neurological symptoms. Despite its transient nature, TIAs are important predictors of subsequent stroke and req [....] » Read More

Prashant Singh Turdikulovna Tma, Speaker at Vaccine Research Conference
Poster Presentation (Virtual)
Prashant Singh Turdikulovna Tma, Tashkant Medical Academy, Uzbekistan

Introduction: Respiratory distress syndrome (RDS), also known as hyaline membrane disease, is a common respiratory complication primarily affecting preterm infants. It is characterized by surfactant deficiency, leading to impaired lung function and respiratory insufficiency. Unde [....] » Read More

Mayank, Speaker at Vaccines Conferences
Poster Presentation (Virtual)
Mayank, Tashkent Medical Academy, Uzbekistan

Introduction: In patients with OSA , there is increased day time sleepiness due to recurrent cortical arousal at night time which are secondary to disease. Patient is morbidly obese with BMI>30 and increased neck circumference. Presentation:  Patient feels hypoxi [....] » Read More

Simmi Simran, Speaker at Immunology Conferences
Poster Presentation (Virtual)
Simmi Simran, Tashkent Medical Academy, Uzbekistan

Introduction: Stress is a prevalent phenomenon in modern society, affecting individuals of all ages and backgrounds. Its impact on mental health is profound, contributing to various psychiatric disorders and decreased well-being. Despite extensive research, a comprehensive und [....] » Read More

Regina Au, Speaker at Vaccine Research Conference
Keynote Presentation (Virtual)
Regina Au, BioMarketing Insight, United States

Antimicrobial resistance (AR) is an urgent and major global public health threat, killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019, a report from The Lancet. In the U.S., more than 2.8 million antimicrobial-resistant infectio [....] » Read More

Carly Contri, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Carly Contri, American Academy of Pediatrics, United States

Abstract: Vaccine hesitancy has increased as pediatric immunization rates have decreased, with lowest rates for children experiencing social determinants of health. To address these issues, 24 immunization partnership grants were awarded to practices and organizations across the [....] » Read More

Vincenzo Alfano, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Vincenzo Alfano, University of Napoli Parthenope, Italy

Attitudes toward vaccination are doubtless an important determinant of public health, and this became evident after the first year of the last COVID-19 pandemic. The issue, long-debated within European societies, especially with respect to occasional surges of diseases in given y [....] » Read More

Megha Mummalaneni, Speaker at Immunology Conferences
Oral Presentation (Virtual)
Megha Mummalaneni, University of Nevada, Reno, School of Medicine , United States

Google Trends, launched on May 11, 2006, serves as a valuable research tool across various healthcare topics. It analyzes daily Google Searches in the United States, offering geographic and temporal pattern data for searched terms (1). Instead of surveying user-stated preferenc [....] » Read More

Chang Yi Wang, Speaker at Immunology Conferences
Oral Presentation (Virtual)
Chang Yi Wang, Chairperson and CSO of United Biomedical Asia , Taiwan

Catastrophic Covid-19: The COVID-19 catastrophe to humanity has been unparalleled in this last 100 years. Vaccine injuries, long COVID, long vax syndromes and persistent infection continue to erode human health and healthcare systems worldwide. The SARS- CoV-2 pandemic may be far [....] » Read More

Chitra Upadhyay, Speaker at Vaccine Research Conference
Oral Presentation (Virtual)
Chitra Upadhyay, Icahn School of Medicine at Mount Sinai , United States

Background: Despite extensive research, an effective prophylactic vaccine against HIV-1 remains elusive. Currently, substantial focus is directed toward developing vaccines that can induce broadly neutralizing antibodies (bNAbs) capable of neutralizing multiple HIV-1 strains. How [....] » Read More

David Craig Wright, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
David Craig Wright, D4 Labs, LLC , United States

During the COVID-19 pandemic, vaccines have produced protective immunity sufficient enough to cause a decrease in hospitalizations and deaths; however, the pandemic continues due to mutational events, predominantly occurring in the S1 sequence of the spike protein of SARS-CoV-2. [....] » Read More

Laleh Yazdanpanah Goharrizi, Speaker at Vaccine Research Conference
Oral Presentation (Virtual)
Laleh Yazdanpanah Goharrizi, Agricultural Research Education and Extension Organization, Iran (Islamic Republic of)

Bacteriophage are commonly referred to as phage and are defined as viruses that infect bacteria. Phage are ubiquitous and require a bacterial host. Recently, there is renewed interest in phage therapy, where phages are used as novel therapeutic agents in the treatment of pathogen [....] » Read More

BITA FOUDA ANDRE AARSENE, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
BITA FOUDA ANDRE AARSENE, WORLD HEALTH ORGANIZATION AFRICAN REGION, Congo, the Democratic Republic of the

Despite significant progress to combat meningitis over the past 20 years, it remains a major public health challenge in the world. Occurrence of meningitis is greatest in the African “meningitis belt”, an area that extends from Senegal to Ethiopia, with an estimated t [....] » Read More

BITA FOUDA ANDRE AARSENE, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
BITA FOUDA ANDRE AARSENE, WORLD HEALTH ORGANIZATION AFRICAN REGION, Congo, the Democratic Republic of the

Background: Bacterial meningitis epidemics remain a major public health challenge in sub-Sharan African meningitis The objective of this study is to describe the bacterial meningitis epidemics and response reported in sub-Saharan African meningitis belt from 2011 to 2023. Meth [....] » Read More

Watsapp